AdventHealth COVID-19 vaccine distribution update

2 individuals in full ppe in a research lab face computers, one looks into a microscope

AdventHealth has launched a new COVID-19 vaccine resource website, www.CoronavirusVaccineFacts.com   to help consumers learn more about the vaccine.

 

For other frequently asked questions:

 

Q: When will AdventHealth receive a COVID-19 vaccine?

A: The U.S. Food & Drug Administration is meeting Dec. 10 to discuss the request for emergency use authorization of a vaccine candidate. We do not have an exact date as of today, but the vaccine could be available as early as mid-December.

 

Q: Is AdventHealth able to store the vaccines that require freezers?

A: AdventHealth is prepared and able to safely store and administer the vaccine.

 

Q: What brand/manufacturer vaccine will AdventHealth receive initially?

A: Pfizer.

 

Q: How many doses will AdventHealth receive?

A: We will receive a limited quantity as part of this initial rollout of the vaccine.

 

Q: Who will initially receive the COVID-19 vaccine?

A: Due to the expected limited initial supply, we will follow distribution guidelines as outlined by the federal and state governments, and National Academy of Medicine, which developed a tiered system. In following this protocol, AdventHealth will administer the vaccine to medical providers and team members working in areas with the most exposure risk.

 

Q: Can the general public receive a COVID-19 vaccine at this time?

A: No. Because of the limited supply, the general public cannot receive a vaccine today. AdventHealth does not have vaccines at its hospitals, physician practices or Centra Care facilities that are for the public at this time.

 

Q: Is the COVID-19 vaccine safe?

A: Extensive clinical trials were conducted with thousands of participants to evaluate the COVID-19 vaccine and generate scientific data and other information for the Food and Drug Administration (FDA) to determine its safety and effectiveness. Additionally, AdventHealth’s COVID-19 Vaccine Scientific Review Committee, as an independent committee, reviewed the process which evaluated the efficacy and safety of the vaccine.

 

Q: How does the COVID-19 vaccine work?

A: The vaccine helps you develop antibodies that make you less susceptible to the disease. It does not use the live virus that causes COVID-19.

 

Q: When will a vaccine be available to the public?

A: There is no exact date, but we are hopeful it could be as early as the Spring.